September 5, 2013 / 2:20 PM / 4 years ago

South Africa's Aspen says talks with GSK over thrombosis drugs continues

JOHANNESBURG (Reuters) - South Africa’s biggest generic drug maker Aspen Pharmacare said on Thursday talks with Britain’s GlaxoSmithKline about its $700 bid for drugs and a factory continues.

Aspen offered to buy GSK’s thrombosis drug brands Arixtra and Fraxiparine, sales of which are in decline, along with a related French factory in June.

Reporting by Tiisetso Motsoeneng; editing by David Dolan

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below